None listed
Conditions
Interventions
Behavioral, Others : The intervention is 'DEX-1-OB', The smartphone application used for personalized exercise, dietary management, glucose monitoring, and medication management functions. Patients wi
Sponsors
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -BMI = 30 kg/m², or 27 kg/m² = BMI < 30 kg/m² with at least one risk factor or comorbidity, who are newly prescribed a GLP-1 receptor agonist (GLP-1 RA, Wegovy® [Semaglutide]). -Agree to concomitant treatment with GLP-1 RA and lifestyle modification therapy (including dietary and exercise interventions).
Exclusion criteria
Exclusion criteria: -Secondary obesity (genetic, congenital, or drug-induced). -Musculoskeletal disorders limiting exercise. -Serious systemic diseases affecting safety or validity. -Use of anti-obesity or weight-control drugs within 3 months. - =5 kg weight loss within 3 months. - History or plan of bariatric surgery. - Pregnancy, lactation, or inadequate contraception. - Poor understanding, compliance, or inability to use the study device properly.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change and percent change in body weight from baseline to week 20. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in metabolic parameters from baseline to week 20.;Change in waist circumference from baseline to week 20;Change in body mass index (BMI) from baseline to week 20 | — |
Countries
Korea, Republic of
Contacts
Public ContactJaehak Kim
Seoul Metropolitan Government Seoul National University Boramae Medical Center
Outcome results
None listed